The reproducibility and quality of the data were demonstrated by scatter plot analysis (Fig. 3).
In order to avoid interference with VEGF released from platelets, the data were demonstrated by showing VEGF plasma levels.
Quality of the data was demonstrated by identifying that the vast majority of reads from each enzyme aligned to restriction sites predicted in silico.
All these results derived from different nuclei and different traceability chains are summarized in Fig. 6, and the consistency of the data is demonstrated by the overlap of their expanded measurement uncertainties.
In Table 4, the information capacity (bits/mm) values of the raw and the postprocessed data are demonstrated.
3, the forecasting error is analyzed, while the results of applying the method to load data are demonstrated in Sect. 4. Finally, Sect. 5 concludes this paper.
The distribution of the filtered signals of the time series and spectrum data are demonstrated in Fig. 2(b) and 2 e), respectively.
The necessity for normalization of the raw data was demonstrated, without the method being very sensitive to the type of normalization.
After a description of the digitizer designed to perform a fast digital sampling of the phoswich signals, the feasibility of particle identification on the sampled data is demonstrated.
The process of analysis of the qualitative data is demonstrated in Table 6.
